미국의 말초신경 손상 시장 규모, 점유율, 동향 분석 보고서 : 제품/치료법별, 수술별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

U.S. Peripheral Nerve Injuries Market Growth & Trends:

The U.S. peripheral nerve injuries market size is estimated to reach USD 712.5 million by 2030, registering a CAGR of 7.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is due to increasing healthcare expenditure in the U.S., an increasing prevalence of peripheral nerve injuries, growing focus on research and development, and a growing patient preference for minimally invasive procedures.

Technological advancements are revolutionizing the field of peripheral nerve injury treatment in the U.S. New and innovative treatment options such as nerve grafts, nerve conduits, and neurostimulation devices are providing improved outcomes and helping patients recover faster. Additionally, the use of minimally invasive surgical techniques, such as end-to-end nerve sutures and nerve decompression procedures, is gaining popularity among patients due to their benefits of faster recovery times. These advancements in medical technology are driving the growth of the market by providing more effective and less invasive treatment options.

Investments from key market players and collaborations between academia, industry, and healthcare institutions are driving R&D efforts, leading to the discovery of new treatment modalities. For instance, in June 2022, Vascudyne, Inc., a leading biotechnology company in regenerative medicine, was awarded a grant from Regenerative Medicine Minnesota for a research study titled "Production of a Peripheral Nerve Wrap Using Tissue Tubes from Regenerative Engineering." The study will be funded with USD 100,000 for one year, starting in June 2022, and will utilize Vascudyne's TRUE Tissue technology.

The COVID-19 pandemic has boosted the demand for minimally invasive procedures as it offer benefits such as shorter recovery times, potentially lower costs, better treatment options, and integration with telemedicine technologies. These factors may impact the market for U.S. peripheral nerve injuries positively.

U.S. Peripheral Nerve Injuries Market Report Highlights:

• Based on product/therapies, Nerve grafting segment dominated the U.S. peripheral nerve injury market share in 2024, accounting for 65.1%, owing to rapid advancements in nerve grafting techniques, such as autografts, allografts, and synthetic conduits
• Based on surgery, direct nerve repair segment dominated the U.S. peripheral nerve injury market and held the largest revenue share of nearly 42.5%. It is considered the gold standard of surgical treatment for severe cases
• Based on application, upper extremities segment held the largest U.S. peripheral nerve injury market share in 2024, accounting for 81.2%. increasing incidence of accidental falls and medical conditions, such as Guillain-Barre syndrome, diabetes, & carpal tunnel syndrome, is expected to drive the segment
• Based on end use, hospitals segment dominated the market in 2024. Increasing number of hospitals and surgical cases in hospitals are expected to boost the segment.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Products/Therapies
  • 1.2.2. Surgery
  • 1.2.3. Application
  • 1.2.4. End use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Peripheral Nerve Injury Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. U.S. Peripheral Nerve Injury Market: Products/Therapies Business Analysis

• 4.1. Products/Therapies Market Share, 2024 & 2030
• 4.2. Products/Therapies Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Products/Therapies, 2018 to 2030 (USD Million)
• 4.4. Nerve Grafting
  • 4.4.1. Nerve Grafting Market, 2018 - 2030 (USD Million)
  • 4.4.2. Autograft
    • 4.4.2.1. Autograft Market, 2018 - 2030 (USD Million)
  • 4.4.3. Allograft
    • 4.4.3.1. Allograft Market, 2018 - 2030 (USD Million)
  • 4.4.4. Stem Cell Therapy
    • 4.4.4.1. Stem Cell Therapy Market, 2018 - 2030 (USD Million)
• 4.5. Biomaterial
  • 4.5.1. Biomaterial Market, 2018 - 2030 (USD Million)
  • 4.5.2. Nerve Conduit
    • 4.5.2.1. Nerve Conduit Market, 2018 - 2030 (USD Million)
  • 4.5.3. Nerve Protector
    • 4.5.3.1. Nerve Protector Market, 2018 - 2030 (USD Million)
  • 4.5.4. Nerve Connector
    • 4.5.4.1. Nerve Connector Market, 2018 - 2030 (USD Million)
  • 4.5.5. Nerve Wraps
    • 4.5.5.1. Nerve Wraps Market, 2018 - 2030 (USD Million)

Chapter 5. U.S. Peripheral Nerve Injury Market: Surgery Business Analysis

• 5.1. Surgery Market Share, 2024 & 2030
• 5.2. Surgery Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Surgery, 2018 to 2030 (USD Million)
• 5.4. Direct Nerve Repair
  • 5.4.1. Direct Nerve Repair Market, 2018 - 2030 (USD Million)
• 5.5. Nerve Grafting
  • 5.5.1. Nerve Grafting Market, 2018 - 2030 (USD Million)
• 5.6. Stem Cell Therapy
  • 5.6.1. Stem Cell Therapy Market, 2018 - 2030 (USD Million)
• 5.7. Internal Neurolysis
  • 5.7.1. Internal Neurolysis Market, 2018 - 2030 (USD Million)
• 5.8. Neurorrhaphy
  • 5.8.1. Neurorrhaphy Market, 2018 - 2030 (USD Million)

Chapter 6. U.S. Peripheral Nerve Injury Market: Application Business Analysis

• 6.1. Application Market Share, 2024 & 2030
• 6.2. Application Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 6.4. Upper Extremities
  • 6.4.1. Upper Extremities Market, 2018 - 2030 (USD Million)
• 6.5. Lower Extremities
  • 6.5.1. Lower Extremities Market, 2018 - 2030 (USD Million)

Chapter 7. U.S. Peripheral Nerve Injury Market: End Use Business Analysis

• 7.1. End Use Market Share, 2024 & 2030
• 7.2. End Use Segment Dashboard
• 7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Hospitals
  • 7.4.1. Hospitals Market, 2018 - 2030 (USD Million)
• 7.5. Clinics
  • 7.5.1. Clinics Market, 2018 - 2030 (USD Million)
• 7.6. Ambulatory Surgical Centers
  • 7.6.1. Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
• 7.7. Others
  • 7.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Overview
• 8.2. Company Market Position Analysis
• 8.3. Company Categorization
• 8.4. Strategy Mapping
• 8.5. Company Profiles/Listing
  • 8.5.1. Axogen Corporation.
    • 8.5.1.1. Overview
    • 8.5.1.2. Financial Performance
    • 8.5.1.3. Product Benchmarking
    • 8.5.1.4. Strategic Initiatives
  • 8.5.2. Stryker
    • 8.5.2.1. Overview
    • 8.5.2.2. Financial Performance
    • 8.5.2.3. Product Benchmarking
    • 8.5.2.4. Strategic Initiatives
  • 8.5.3. Regenity
    • 8.5.3.1. Overview
    • 8.5.3.2. Financial Performance
    • 8.5.3.3. Product Benchmarking
    • 8.5.3.4. Strategic Initiatives
  • 8.5.4. Integra LifeSciences Corporation.
    • 8.5.4.1. Overview
    • 8.5.4.2. Financial Performance
    • 8.5.4.3. Product Benchmarking
    • 8.5.4.4. Strategic Initiatives
  • 8.5.5. TOYOBO CO., LTD.
    • 8.5.5.1. Overview
    • 8.5.5.2. Financial Performance
    • 8.5.5.3. Product Benchmarking
    • 8.5.5.4. Strategic Initiatives
  • 8.5.6. Alafair Biosciences, Inc.
    • 8.5.6.1. Overview
    • 8.5.6.2. Financial Performance
    • 8.5.6.3. Product Benchmarking
    • 8.5.6.4. Strategic Initiatives
  • 8.5.7. SYNOVIS MICRO COMPANIES ALLIANCE, INC., (BAXTER INTERNATIONAL INC.)
    • 8.5.7.1. Overview
    • 8.5.7.2. Financial Performance
    • 8.5.7.3. Product Benchmarking
    • 8.5.7.4. Strategic Initiatives